| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.1M | +95.4% |
| R&D Expense | $136.8M | +48.2% |
| SG&A Expense | $71.1M | +40.1% |
| Operating Income | -$232.5M | -47.4% |
| Pre-tax Income | -$331.6M | -110.2% |
| Income Tax | $59K | +22.9% |
| Net Income | -$331.6M | -110.2% |
| EPS (Basic) | -$1.56 | -100.0% |
| EPS (Diluted) | -$1.56 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.4M | +52.5% |
| Short-term Investments | $285.9M | -10.6% |
| Accounts Receivable | $10.2M | -11.2% |
| Current Assets | $378.8M | -2.9% |
| Total Assets | $508.4M | -8.2% |
| Current Liabilities | $36.1M | -2.9% |
| Total Liabilities | $124.5M | +81.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$105.7M | -34.1% |
| Capital Expenditures | $18.0M | +31.3% |
| Investing Cash Flow | $82.7M | +20.3% |
| Financing Cash Flow | $41.7M | +2267.2% |
| Free Cash Flow | -$123.7M | -33.7% |
| -100.0% |
| Stockholders' Equity |
| $383.9M |
| -20.9% |